Document:

Exhibit 10.2

 

REGISTRATION RIGHTS
AGREEMENT

 

This REGISTRATION
RIGHTS AGREEMENT (this “Agreement”), dated as of May 17, 2022, is by and between White Lion Capital,
LLC, a Nevada limited liability company (the “Investor”), and Nukkleus Inc., a Delaware corporation (the “Company”).

 

RECITALS

 

A.
The parties desire that, upon the terms and subject to the conditions and limitations set forth herein, during the Investment Period,
the Company may issue and sell to the Investor, from time to time as provided herein, and the Investor shall purchase from the Company,
up to the lesser of (i) $75,000,000 in aggregate gross purchase price of newly issued Common Stock and (ii) the Exchange Cap
(if applicable under Section 3.3 of the Common Stock Purchase Agreement);

 

B.
Pursuant to the terms of, and in consideration for the Investor entering into, the Purchase Agreement, and to induce the Investor to execute
and deliver the Purchase Agreement, the Company has agreed to provide the Investor with certain registration rights with respect to the
Registrable Securities (as defined herein) as set forth herein.

 

C.
The Company has entered into an Agreement and Plan of Merger, dated as of February 22, 2022, with Brilliant Acquisition Corporation, a
blank check company incorporated as a British Virgin Islands company (the “SPAC”) (as amended from time to time,
the “Merger Agreement”);

 

D.
following the consummation of the transactions contemplated by the Merger Agreement (the “Merger Closing”),
the Company shall survive as the sole stockholder of the SPAC, with the Company’s common stock (the “Common Stock”)
registered under Section 12(b) of the Exchange Act;

 

AGREEMENT

 

NOW,
THEREFORE, in consideration of the representations, warranties, covenants and agreements contained herein and in the Purchase
Agreement, and for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, intending to be
legally bound hereby, the Company and the Investor hereby agree as follows:

 

	1.	Definitions.

 

Capitalized
terms used herein and not otherwise defined herein shall have the respective meanings set forth in the Purchase Agreement. As used in
this Agreement, the following terms shall have the following meanings:

 

(a)
“Agreement” shall have the meaning assigned to such term in the preamble of this Agreement

 

(b)
“Allowable Grace Period” shall have the meaning assigned to such term in Section 3(p).

 

(c)
“Blue Sky Filing” shall have the meaning assigned to such term in Section 6(a).

 

     

     

    

 

(d)
“Business Day” means any day other than Saturday, Sunday or any other day on which commercial banks in New York,
New York are authorized or required by law to remain closed.

 

(e)
“Claims” shall have the meaning assigned to such term in Section 6(a).

 

(f)
“Closing Date” shall mean the date of this Agreement.

 

(g)
“Commission” means the U.S. Securities and Exchange Commission or any successor entity.

 

(h)
“Common Stock” shall have the meaning assigned to such term in the recitals to this Agreement.

 

(i)
“Company” shall have the meaning assigned to such term in the preamble of this Agreement.

 

(j)
“Effective Date” means the date that the applicable Registration Statement has been declared effective by the
Commission.

 

(k)
“Indemnified Damages” shall have the meaning assigned to such term in Section 6(a).

 

(l)
“Initial Registration Statement” shall have the meaning assigned to such term in Section 2(a).

 

(m)
“Investor” shall have the meaning assigned to such term in the preamble of this Agreement.

 

(n)
“Investor Party” and “Investor Parties” shall have the meaning assigned to such terms in Section 6(a).

 

(o)
“Legal Counsel” shall have the meaning assigned to such term in Section 2(b).

 

(p)
“New Registration Statement” shall have the meaning assigned to such term in Section 2(c).

 

(q)
“Person” means any person or entity, whether a natural person, trustee, corporation, partnership, limited partnership,
limited liability company, trust, unincorporated organization, business association, firm, joint venture, governmental agency or authority.

 

(r)
“Prospectus” means the prospectus in the form included in the Registration Statement at the applicable Effective
Date of the Registration Statement, as supplemented from time to time by any Prospectus Supplement, including the documents incorporated
by reference therein.

 

(s)
“Prospectus Supplement” means any prospectus supplement to the Prospectus filed with the Commission from time
to time pursuant to Rule 424(b) under the Securities Act, including the documents incorporated by reference therein.

 

(t)
“Purchase Agreement” shall have the meaning assigned to such term in the recitals to this Agreement.

 

    2

     

    

 

(u)
“register,” “registered,” and “registration” refer to a
registration effected by preparing and filing one or more Registration Statements in compliance with the Securities Act and pursuant to
Rule 415 and the declaration of effectiveness of such Registration Statement(s) by the Commission.

 

(v)
“Registrable Securities” means all of (i) the Shares, (ii) the Commitment Shares and (iii) any capital
stock of the Company issued or issuable with respect to such Shares or Commitment Shares, including, without limitation, (1) as a
result of any stock split, stock dividend, recapitalization, exchange or similar event or otherwise and (2) shares of capital stock
of the Company into which the shares of Common Stock are converted or exchanged and shares of capital stock of a successor entity into
which the shares of Common Stock are converted or exchanged, in each case until such time as such securities cease to be Registrable Securities
pursuant to Section 2(e).

 

(w)
“Registration Statement” means a registration statement or registration statements of the Company filed under
the Securities Act covering the resale by the Investor of Registrable Securities, as such registration statement or registration statements
may be amended and supplemented from time to time, including all documents filed as part thereof or incorporated by reference therein.

 

(x)
“Registration Period” shall have the meaning assigned to such term in Section 3(a).

 

(y)
“Rule 144” means Rule 144 promulgated by the Commission under the Securities Act, as such rule may be amended
from time to time, or any other similar or successor rule or regulation of the Commission that may at any time permit the Investor to
sell securities of the Company to the public without registration.

 

(z)
“Rule 415” means Rule 415 promulgated by the Commission under the Securities Act, as such rule may be amended
from time to time, or any other similar or successor rule or regulation of the Commission providing for offering securities on a delayed
or continuous basis.

 

(aa)
“Staff” shall have the meaning assigned to such term in Section 2(c).

 

(bb)
“Violations” shall have the meaning assigned to such term in Section 6(a).

 

	2.	Registration.

 

(a) Mandatory
Registration. The Company shall use its commercially reasonable efforts to, within sixty (60) days of Merger Closing Date as defined
in the Common Stock Purchase Agreement, file with the Commission an initial Registration Statement on Form S-1 (or any successor
form) covering the resale by the Investor of (i) all of the Commitment Shares and (ii) the maximum number of other Registrable
Securities as shall be permitted to be included thereon in accordance with applicable Commission rules, regulations and interpretations
so as to permit the resale of such Registrable Securities by the Investor under Rule 415 under the Securities Act at then prevailing market
prices (and not fixed prices) (the “Initial Registration Statement”). The Initial Registration Statement shall
contain the “Selling Stockholder” and “Plan of Distribution” sections in substantially the form attached hereto
as Exhibit B. The Company shall use its commercially reasonable efforts to have the Initial Registration Statement declared
effective by the Commission as soon as reasonably practicable following the filing thereof with the Commission.

 

    3

     

    

 

(b) Legal
Counsel. Subject to Section 5 hereof, the Investor shall have the right to select one legal counsel to review and oversee, solely
on its behalf, any registration pursuant to this Section 2 (“Legal Counsel”), which shall be as designated
in writing by the Investor. The Company shall have no obligation to reimburse the Investor for any and all legal fees and expenses of
the Legal Counsel incurred in connection with the transactions contemplated hereby.

 

(c) Sufficient
Number of Shares Registered. If at any time all Registrable Securities are not covered by the Initial Registration Statement filed
pursuant to Section 2(a) as a result of Section 2(d) or otherwise, the Company shall use its commercially reasonable efforts
to file with the Commission one or more additional Registration Statements so as to cover all of the Registrable Securities not covered
by such initial Registration Statement, in each case, as soon as practicable (taking into account any position of the staff of the Commission
(the “Staff”) with respect to the date on which the Staff will permit such additional Registration Statement(s)
to be filed with the Commission and the rules and regulations of the Commission) (each such additional Registration Statement, a “New
Registration Statement”). The Company shall use its commercially reasonable efforts to cause each such New Registration
Statement to become effective as soon as reasonably practicable following the filing thereof with the Commission.

 

(d) Offering.
If the Staff or the Commission seeks to characterize any offering pursuant to a Registration Statement filed pursuant to this Agreement
as constituting an offering of securities that does not permit such Registration Statement to become effective and be used for resales
by the Investor on a delayed or continuous basis under Rule 415 at then-prevailing market prices (and not fixed prices), or if after the
filing of any Registration Statement pursuant to Section 2(a) or Section 2(c), the Company is otherwise required by the Staff
or the Commission to reduce the number of Registrable Securities included in such Registration Statement, then the Company shall reduce
the number of Registrable Securities to be included in such Registration Statement (after reasonable consultation with the Investor and
Legal Counsel as to the specific Registrable Securities to be removed therefrom) until such time as the Staff and the Commission shall
so permit such Registration Statement to become effective and be used as aforesaid. Notwithstanding anything in this Agreement to the
contrary, if after giving effect to the actions referred to in the immediately preceding sentence, the Staff or the Commission does not
permit such Registration Statement to become effective and be used for resales by the Investor on a delayed or continuous basis under
Rule 415 at then-prevailing market prices (and not fixed prices), the Company shall not request acceleration of the Effective Date of
such Registration Statement, the Company shall promptly (but in no event later than 48 hours) request the withdrawal of such Registration
Statement pursuant to Rule 477 under the Securities Act. In the event of any reduction in Registrable Securities pursuant to this paragraph,
the Company shall use its commercially reasonable efforts to file one or more New Registration Statements with the Commission in accordance
with Section 2(c) until such time as all Registrable Securities have been included in Registration Statements that have been declared
effective and the Prospectuses contained therein are available for use by the Investor.

 

    4

     

    

 

(e)
Any Registrable Security shall cease to be a “Registrable Security” at the earliest of the following: (i) when a Registration
Statement covering such Registrable Security becomes or has been declared effective by the Commission and such Registrable Security has
been sold or disposed of pursuant to such effective Registration Statement; (ii) when such Registrable Security is held by the Company
or one of its Subsidiaries; and (iii) the date that is the later of (A) the first (1st) anniversary of the date of
termination of the Purchase Agreement in accordance with Article VIII of the Purchase Agreement and (B) the first (1st)
anniversary of the date of the last sale of any Registrable Securities to the Investor pursuant to the Purchase Agreement.

 

	3.	Related Obligations.

 

The
Company shall use its commercially reasonable efforts to effect the registration of the Registrable Securities in accordance with the
intended method of disposition thereof, and, pursuant thereto, during the term of this Agreement, the Company shall have the following
obligations:

 

(a)
Subject to Allowable Grace Periods, the Company shall use its commercially reasonable efforts to keep each Registration Statement effective
(and the Prospectus contained therein available for use) pursuant to Rule 415 for resales by the Investor on a continuous basis at then-prevailing
market prices (and not fixed prices) at all times until the earlier of (i) the date on which the Investor shall have sold all of
the Registrable Securities covered by such Registration Statement and (ii) the date of termination of the Purchase Agreement if as
of such termination date the Investor holds no Registrable Securities (or, if applicable, the date on which such securities cease to be
Registrable Securities after the date of termination of the Purchase Agreement) (the “Registration Period”).
Notwithstanding anything to the contrary contained in this Agreement (but subject to the provisions of Section 3(p) hereof), the
Company shall ensure that, when filed and at all times while effective, each Registration Statement (including, without limitation, all
amendments and supplements thereto) and the Prospectus (including, without limitation, all amendments and supplements thereto) used in
connection with such Registration Statement shall not contain any untrue statement of a material fact or omit to state a material fact
required to be stated therein, or necessary to make the statements therein (in the case of Prospectuses, in the light of the circumstances
in which they were made) not misleading. The Company shall submit to the Commission, as soon as reasonably practicable after the date
that the Company learns that no review of a particular Registration Statement will be made by the Staff or that the Staff has no further
comments on a particular Registration Statement (as the case may be), a request for acceleration of effectiveness of such Registration
Statement to a time and date as soon as reasonably practicable in accordance with Rule 461 under the Securities Act.

 

    5

     

    

 

(b)
Subject to Section 3(p) of this Agreement, the Company shall use its commercially reasonable efforts to prepare and file with the
Commission such amendments (including, without limitation, post-effective amendments) and supplements to each Registration Statement and
the Prospectus used in connection with each such Registration Statement, which Prospectus is to be filed pursuant to Rule 424 promulgated
under the Securities Act, as may be necessary to keep each such Registration Statement effective (and the Prospectus contained therein
current and available for use) at all times during the Registration Period for such Registration Statement, and, during such period, comply
with the provisions of the Securities Act with respect to the disposition of all Registrable Securities of the Company required to be
covered by such Registration Statement until such time as all of such Registrable Securities shall have been disposed of in accordance
with the intended methods of disposition by the Investor. Without limiting the generality of the foregoing, the Company covenants and
agrees that (i) at or before 8:30 a.m. (New York City time) on the second (2nd) Trading Day immediately following the
Effective Date of the Initial Registration Statement and any New Registration Statement (or any post-effective amendment thereto), the
Company shall file with the Commission in accordance with Rule 424(b) under the Securities Act the final Prospectus to be used in connection
with sales pursuant to such Registration Statement (or post-effective amendment thereto), and (ii) if the transactions contemplated
by any Purchase are material to the Company (individually or collectively with all other prior Purchases, the consummation of which have
not previously been reported in any Prospectus Supplement filed with the Commission under Rule 424(b) under the Securities Act or in any
report, statement or other document filed by the Company with the Commission under the Exchange Act), or if otherwise required under the
Securities Act (or the interpretations of the Commission thereof), in each case as reasonably determined by the Company and the Investor,
then, at or before 8:30 a.m., New York City time, on the first (1st) Trading Day immediately following the Purchase Settlement
Date, if a Purchase Notice was properly delivered to the Investor hereunder in connection with such Purchase, the Company shall file with
the Commission a Prospectus Supplement pursuant to Rule 424(b) under the Securities Act with respect to the Purchase(s), the
total Purchase Amount for the Shares subject to such Purchase(s) (as applicable), the applicable Purchase Amount(s) for such Shares and
the net proceeds that are to be (and, if applicable, have been) received by the Company from the sale of such Shares. To the extent not
previously disclosed in the Prospectus or a Prospectus Supplement, the Company shall disclose in its Quarterly Reports on Form 10-Q and
in its Annual Reports on Form 10-K the information described in the immediately preceding sentence relating to all Purchase(s)
consummated during the relevant fiscal quarter and shall file such Quarterly Reports and Annual Reports with the Commission within the
applicable time period prescribed for such report under the Exchange Act. In the case of amendments and supplements to any Registration
Statement on Form S-1 or Prospectus related thereto which are required to be filed pursuant to this Agreement (including, without
limitation, pursuant to this Section 3(b)) by reason of the Company filing a report on Form 8-K, Form 10-Q or
Form 10-K or any analogous report under the Exchange Act, the Company shall have incorporated such report by reference into
such Registration Statement and Prospectus, if applicable, or shall file such amendments or supplements to the Registration Statement
or Prospectus with the Commission on the same day on which the Exchange Act report is filed which created the requirement for the Company
to amend or supplement such Registration Statement or Prospectus, for the purpose of including or incorporating such report into such
Registration Statement and Prospectus. The Company consents to the use of the Prospectus (including, without limitation, any supplement
thereto) included in each Registration Statement in accordance with the provisions of the Securities Act and with the securities or “Blue
Sky” laws of the jurisdictions in which the Registrable Securities may be sold by the Investor, in connection with the resale of
the Registrable Securities and for such period of time thereafter as such Prospectus (including, without limitation, any supplement thereto)
(or in lieu thereof, the notice referred to in Rule 173(a) under the Securities Act) is required by the Securities Act to be delivered
in connection with resales of Registrable Securities.

 

    6

     

    

 

(c)
The Company shall (A) reasonably permit Legal Counsel an opportunity to review and comment upon (i) each Registration Statement
prior to its filing with the Commission and (ii) all amendments and supplements to each Registration Statement (including, without
limitation, the Prospectus contained therein) (except for Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current
Reports on Form 8-K, and any similar or successor reports or Prospectus Supplements the contents of which is limited to that
set forth in such reports) prior to their filing with the Commission, and (B) shall reasonably consider any comments of the Investor
and Legal Counsel on any such Registration Statement or amendment or supplement thereto or to any Prospectus contained therein. The Company
shall reasonably promptly furnish to Legal Counsel, without charge, (i) electronic copies of any correspondence from the Commission
or the Staff to the Company or its representatives relating to each Registration Statement (which correspondence shall be redacted to
exclude any material, non-public information regarding the Company or any of its Subsidiaries), (ii) after the same is
prepared and filed with the Commission, one (1) electronic copy of each Registration Statement and any amendment(s) and supplement(s)
thereto, including, without limitation, financial statements and schedules, all documents incorporated therein by reference, if requested
by the Investor, and all exhibits and (iii) upon the effectiveness of each Registration Statement, one (1) electronic copy of
the Prospectus included in such Registration Statement and all amendments and supplements thereto; provided, however, the Company shall
not be required to furnish any document (other than the Prospectus, which may be provided in .PDF format) to Legal Counsel to the extent
such document is available on EDGAR).

 

(d)
Without limiting any obligation of the Company under the Purchase Agreement, the Company shall reasonably promptly furnish to the Investor,
without charge, (i) after the same is prepared and filed with the Commission, at least one (1) electronic copy of each Registration
Statement and any amendment(s) and supplement(s) thereto, including, without limitation, financial statements and schedules, all documents
incorporated therein by reference, if requested by the Investor, all exhibits thereto, (ii) upon the effectiveness of each Registration
Statement, one (1) electronic copy of the Prospectus included in such Registration Statement and all amendments and supplements thereto
(or such other number of copies as the Investor may reasonably request from time to time) and (iii) such other documents, including,
without limitation, copies of any final Prospectus and any Prospectus Supplement thereto, as the Investor may reasonably request from
time to time in order to facilitate the disposition of the Registrable Securities owned by the Investor; provided, however, the Company
shall not be required to furnish any document (other than the Prospectus, which may be provided in .PDF format) to the Investor to the
extent such document is available on EDGAR).

 

(e)
The Company shall take such action as is reasonably necessary to (i) register and qualify, unless an exemption from registration
and qualification applies, the resale by the Investor of the Registrable Securities covered by a Registration Statement under such other
securities or “Blue Sky” laws of all applicable jurisdictions in the United States, (ii) prepare and file in those jurisdictions,
such amendments (including, without limitation, post-effective amendments) and supplements to such registrations and qualifications as
may be necessary to maintain the effectiveness thereof during the Registration Period, (iii) take such other actions as may be reasonably
necessary to maintain such registrations and qualifications in effect at all times during the Registration Period, and (iv) take
all other actions reasonably necessary to qualify the Registrable Securities for sale in such jurisdictions; provided, however,
the Company shall not be required in connection therewith or as a condition thereto to (x) qualify to do business in any jurisdiction
where it would not otherwise be required to qualify but for this Section 3(e), (y) subject itself to general taxation in any
such jurisdiction, or (z) file a general consent to service of process in any such jurisdiction. The Company shall reasonably promptly
notify Legal Counsel and the Investor of the receipt by the Company of any notification with respect to the suspension of the registration
or qualification of any of the Registrable Securities for sale under the securities or “Blue Sky” laws of any jurisdiction
in the United States or its receipt of actual notice of the initiation or threatening of any proceeding for such purpose.

 

    7

     

    

 

(f)
The Company shall notify Legal Counsel and the Investor in writing of any event, as promptly as reasonably practicable after becoming
aware of such event, as a result of which the Prospectus included in a Registration Statement, as then in effect, includes an untrue statement
of a material fact or omits to state a material fact required to be stated therein or necessary to make the statements therein, in the
light of the circumstances under which they were made, not misleading (and shall furnish a copy of such supplement or amendment to Legal
Counsel and the Investor upon reasonable request). The Company shall also reasonably promptly notify Legal Counsel and the Investor in
writing (i) when a Prospectus or any Prospectus Supplement or post-effective amendment has been filed, when a Registration Statement
or any post-effective amendment has become effective (notification of such effectiveness shall be delivered to Legal Counsel and the Investor
by facsimile or e-mail on the same day of such effectiveness), and when the Company receives written notice from the Commission
that a Registration Statement or any post-effective amendment will be reviewed by the Commission, (ii) of any request by the Commission
for amendments or supplements to a Registration Statement or related Prospectus or related information, (iii) of the Company’s
reasonable determination that a post-effective amendment to a Registration Statement would be appropriate and (iv) of the receipt
of any request by the Commission or any other federal or state governmental authority for any additional information relating to the Registration
Statement or any amendment or supplement thereto or any related Prospectus. The Company shall respond as promptly as reasonably practicable
to any comments received from the Commission with respect to a Registration Statement or any amendment thereto. Nothing in this Section 3(f)
shall limit any obligation of the Company under the Purchase Agreement.

 

(g)
The Company shall (i) use its commercially reasonable efforts to prevent the issuance of any stop order or other suspension of effectiveness
of a Registration Statement or the use of any Prospectus contained therein, or the suspension of the qualification, or the loss of an
exemption from qualification, of any of the Registrable Securities for sale in any jurisdiction and, if such an order or suspension is
issued, to obtain the withdrawal of such order or suspension at the earliest possible time and (ii) notify Legal Counsel and the
Investor of the issuance of such order and the resolution thereof or its receipt of actual notice of the initiation or threat of any proceeding.

 

(h)
The Company shall hold in confidence and not make any disclosure of information concerning the Investor provided to the Company unless
(i) disclosure of such information is necessary to comply with federal or state securities laws, (ii) the disclosure of such
information is necessary to avoid or correct a misstatement or omission in any Registration Statement or is otherwise required to be disclosed
in such Registration Statement pursuant to the Securities Act, (iii) the release of such information is ordered pursuant to a subpoena
or other final, non-appealable order from a court or governmental body of competent jurisdiction, or (iv) such information
has been made generally available to the public other than by disclosure in violation of this Agreement or any other Transaction Document.
The Company agrees that it shall, upon learning that disclosure of such information concerning the Investor is sought in or by a court
or governmental body of competent jurisdiction or through other means, give prompt written notice to the Investor and allow the Investor,
at the Investor’s expense, to undertake appropriate action to prevent disclosure of, or to obtain a protective order for, such information.

 

    8

     

    

 

(i)
Without limiting any obligation of the Company under the Purchase Agreement, the Company shall use its commercially reasonable efforts
either to (i) cause all of the Registrable Securities covered by each Registration Statement to be listed on the Trading Market,
or (ii) secure designation and quotation of all of the Registrable Securities covered by each Registration Statement on another Eligible
Market. The Company shall pay all fees and expenses in connection with satisfying its obligation under this Section 3(i).

 

(j)
The Company shall reasonably cooperate with the Investor and, to the extent applicable, facilitate the timely preparation and delivery
of Registrable Securities, as DWAC Shares, to be offered pursuant to a Registration Statement and enable such DWAC Shares to be in such
denominations or amounts (as the case may be) as the Investor may reasonably request from time to time. The Investor hereby agrees that
it shall cooperate with the Company, its counsel and its transfer agent in connection with any issuances of DWAC Shares, and hereby represents,
warrants and covenants to the Company that that it will resell such DWAC Shares only pursuant to the Registration Statement in which such
DWAC Shares are included, in a manner described under the caption “Plan of Distribution” in such Registration Statement, and
in a manner in compliance with all applicable U.S. federal and state securities laws, rules and regulations, including, without limitation,
any applicable prospectus delivery requirements of the Securities Act. At the time such DWAC shares are offered and sold pursuant to the
Registration Statement, such DWAC Shares shall be free from all restrictive legends may be transmitted by the transfer agent to the Investor
by crediting an account at DTC as directed in writing by the Investor.

 

(k)
Upon the written request of the Investor, the Company shall as soon as reasonably practicable after receipt of notice from the Investor
and subject to Section 3(p) hereof, (i) incorporate in a Prospectus Supplement or post-effective amendment such information
as the Investor reasonably requests to be included therein relating to the sale and distribution of Registrable Securities, including,
without limitation, information with respect to the number of Registrable Securities being offered or sold, the purchase price being paid
therefor and any other terms of the offering of the Registrable Securities to be sold in such offering; (ii) make all required filings
of such Prospectus Supplement or post-effective amendment after being notified of the matters to be incorporated in such Prospectus Supplement
or post-effective amendment; and (iii) supplement or make amendments to any Registration Statement or Prospectus contained therein
if reasonably requested by the Investor.

 

(l)
Reserved.

 

(m)
The Company shall make generally available to its security holders (which may be satisfied by making such information available on EDGAR)
as soon as practical, but not later than ninety (90) days after the close of the period covered thereby, an earnings statement (in
form complying with, and in the manner provided by, the provisions of Rule 158 under the Securities Act) covering a twelve-month period
beginning not later than the first day of the Company’s fiscal quarter next following the applicable Effective Date of each Registration
Statement.

 

(n)
The Company shall otherwise use its commercially reasonable efforts to comply with all applicable rules and regulations of the Commission
in connection with any registration hereunder.

 

    9

     

    

 

(o)
Within one (1) Business Day after each Registration Statement which covers Registrable Securities is declared effective by the Commission,
the Company shall deliver, and shall cause legal counsel for the Company to deliver, to the transfer agent for such Registrable Securities
(with copies to the Investor) confirmation that such Registration Statement has been declared effective by the Commission in the form
attached hereto as Exhibit A.

 

(p)
Notwithstanding anything to the contrary contained herein (but subject to the last sentence of this Section 3(p)), at any time after
the Effective Date of a particular Registration Statement, the Company may, upon written notice to the Investor, suspend the Investor’s
use of any Prospectus that is a part of any Registration Statement (in which event the Investor shall discontinue sales of the Registrable
Securities pursuant to such Registration Statement contemplated by this Agreement, but shall settle any previously made sales of Registrable
Securities) if the Company (x) is pursuing an acquisition, merger, tender offer, reorganization, disposition or other similar transaction
and the Company determines in good faith that (A) the Company’s ability to pursue or consummate such a transaction would be
materially adversely affected by any required disclosure of such transaction in such Registration Statement or other registration statement
or (B) such transaction renders the Company unable to comply with Commission requirements, in each case under circumstances that
would make it impractical or inadvisable to cause any Registration Statement (or such filings) to be used by Investor or to promptly amend
or supplement any Registration Statement contemplated by this Agreement on a post effective basis, as applicable, or (y) has experienced
some other material non-public event the disclosure of which at such time, in the good faith judgment of the Company, would
materially adversely affect the Company (each, an “Allowable Grace Period”); provided, however, that in
no event shall the Investor be suspended from selling Registrable Securities pursuant to any Registration Statement for a period that
exceeds 45 consecutive Trading Days or an aggregate of 90 days in any 365-day period; and provided, further, that the Company
shall not effect any such suspension during the Valuation period following the Purchase Date for each Purchase. Upon disclosure of such
information or the termination of the condition described above, the Company shall provide reasonably prompt notice to the Investor and
shall reasonably promptly terminate any suspension of sales it has put into effect and shall take such other reasonable actions to permit
registered sales of Registrable Securities as contemplated in this Agreement (including as set forth in the first sentence of Section 3(f)
with respect to the information giving rise thereto unless such material, non-public information is no longer applicable). Notwithstanding
anything to the contrary contained in this Section 3(p), the Company shall cause its transfer agent to deliver DWAC Shares to a transferee
of the Investor in accordance with the terms of the Purchase Agreement in connection with any sale of Registrable Securities with
respect to which (i) the Company has made a sale to the Investor and (ii) the Investor has entered into a contract for sale,
and delivered a copy of the Prospectus included as part of the particular Registration Statement to the extent applicable, in each case
prior to the Investor’s receipt of the notice of an Allowable Grace Period and for which the Investor has not yet settled.

 

    10

     

    

 

	4.	Obligations of the Investor.

 

(a)
At least five (5) Business Days prior to the first anticipated filing date of each Registration Statement (or such shorter period
to which the parties agree, the Investor’s agreement not to be unreasonably withheld, conditioned or delayed), the Company shall
notify the Investor in writing of the information the Company requires from the Investor with respect to such Registration Statement.
It shall be a condition precedent to the obligations of the Company to complete the registration pursuant to this Agreement with respect
to the Registrable Securities of the Investor that the Investor shall furnish to the Company such information regarding itself, the Registrable
Securities held by it and the intended method of disposition of the Registrable Securities held by it, as shall be reasonably required
to effect and maintain the effectiveness of the registration of such Registrable Securities and shall execute such documents in connection
with such registration as the Company may reasonably request.

 

(b)
The Investor, by its acceptance of the Commitment Shares and Registrable Securities, agrees to cooperate with the Company as reasonably
requested by the Company in connection with the preparation and filing of each Registration Statement hereunder, unless the Investor has
notified the Company in writing of the Investor’s election to exclude all of the Investor’s Registrable Securities from such
Registration Statement.

 

(c)
The Investor agrees that, upon receipt of any notice from the Company of the happening of any event of the kind described in Section 3(p)
or the first sentence of Section 3(f), the Investor shall immediately discontinue disposition of Registrable Securities pursuant
to any Registration Statement(s) covering such Registrable Securities until the Investor’s receipt of the copies of the supplemented
or amended Prospectus contemplated by Section 3(p) or the first sentence of Section 3(f) or receipt of notice that no supplement
or amendment is required. Notwithstanding anything to the contrary in this Section 4(c), the Company shall cause its transfer agent
to deliver DWAC Shares to a transferee of the Investor in accordance with the terms of the Purchase Agreement in connection with any sale
of Registrable Securities with respect to which the Investor has entered into a contract for sale prior to the Investor’s receipt
of a notice from the Company of the happening of any event of the kind described in Section 3(p) or the first sentence of Section 3(f)
and for which the Investor has not yet settled.

 

(d)
The Investor covenants and agrees that it shall comply with the prospectus delivery and other requirements of the Securities Act as applicable
to it in connection with sales of Registrable Securities pursuant to a Registration Statement.

 

	5.	Expenses of Registration.

 

All
reasonable expenses of the Company, other than sales or brokerage commissions and fees and disbursements of counsel for, and other expenses
of, the Investor, incurred in connection with registrations, filings or qualifications pursuant to Sections 2 and 3, including, without
limitation, all registration, listing and qualifications fees, printers and accounting fees, and fees and disbursements of counsel for
the Company, shall be paid by the Company.

 

    11

     

    

 

	6.	Indemnification.

 

(a)
In the event any Registrable Securities are included in any Registration Statement under this Agreement, to the fullest extent permitted
by law, the Company will, and hereby does, indemnify, hold harmless and defend the Investor, each of its directors, officers, shareholders,
members, partners, employees, agents, representatives (and any other Persons with a functionally equivalent role of a Person holding such
titles notwithstanding the lack of such title or any other title) and each Person, if any, who controls the Investor within the meaning
of the Securities Act or the Exchange Act and each of the directors, officers, shareholders, members, partners, employees, agents, representatives
(and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding the lack of such title or any
other title) of such controlling Persons (each, an “Investor Party” and collectively, the “Investor
Parties”), against any losses, obligations, claims, damages, liabilities, contingencies, judgments, fines, penalties, charges,
costs (including, without limitation, court costs, reasonable attorneys’ fees, costs of defense and investigation), amounts paid
in settlement or expenses, joint or several, (collectively, “Claims”) reasonably incurred in investigating,
preparing or defending any action, claim, suit, inquiry, proceeding, investigation or appeal taken from the foregoing by or before any
court or governmental, administrative or other regulatory agency, body or the Commission, whether pending or threatened, whether or not
an Investor Party is or may be a party thereto (“Indemnified Damages”), to which any of them may become subject
insofar as such Claims (or actions or proceedings, whether commenced or threatened, in respect thereof) arise out of or are based upon:
(i) any untrue statement or alleged untrue statement of a material fact in a Registration Statement or any post-effective amendment
thereto or in any filing made in connection with the qualification of the offering under the securities or other “Blue Sky”
laws of any jurisdiction in which Registrable Securities are offered (“Blue Sky Filing”), or the omission or
alleged omission to state a material fact required to be stated therein or necessary to make the statements therein not misleading or
(ii) any untrue statement or alleged untrue statement of a material fact contained in any Prospectus (as amended or supplemented)
or in any Prospectus Supplement or the omission or alleged omission to state therein any material fact necessary to make the statements
made therein, in light of the circumstances under which the statements therein were made, not misleading (the matters in the foregoing
clauses (i) and (ii) being, collectively, “Violations”). Subject to Section 6(c), the Company shall
reimburse an Investor Party, reasonably promptly as such expenses are incurred and are due and payable, for any reasonable legal fees
or other reasonable expenses incurred by such Investor Party in connection with investigating or defending any such Claim; provided, however,
the indemnity agreement contained in this Section 6(a) and the agreement with respect to contribution contained in Section 7
shall not apply to amounts paid in settlement of any Claim if such settlement is effected without the prior written consent of the Company,
which consent shall not be unreasonably withheld or delayed. Notwithstanding anything to the contrary contained herein, the indemnification
agreement contained in this Section 6(a): (i) shall not apply to a Claim by an Investor Party arising out of or based upon a Violation
which occurs in reliance upon and in conformity with information furnished in writing to the Company by any Investor Party for any Investor
Party expressly for use in connection with the preparation of such Registration Statement, Prospectus or Prospectus Supplement or any
such amendment thereof or supplement thereto (it being hereby acknowledged and agreed that the written information set forth on Exhibit
C attached hereto is the only written information furnished to the Company by or on behalf of the Investor expressly for use
in any Registration Statement, Prospectus or Prospectus Supplement); (ii) shall not be available to the Investor to the extent such
Claim is based on a failure of the Investor to deliver or to cause to be delivered the Prospectus (as amended or supplemented) made available
by the Company (to the extent applicable), including, without limitation, a corrected Prospectus, if such Prospectus (as amended or supplemented)
or corrected Prospectus was timely made available by the Company pursuant to Section 3(d) and then only if, and to the extent that,
following the receipt of the corrected Prospectus no grounds for such Claim would have existed; and (iii) shall not apply to amounts
paid in settlement of any Claim if such settlement is effected without the prior written consent of the Company, which consent shall not
be unreasonably withheld or delayed. Such indemnity shall remain in full force and effect regardless of any investigation made by or on
behalf of the Investor Party and shall survive the transfer of any of the Registrable Securities by the Investor pursuant to Section 9.

 

    12

     

    

 

(b)
In connection with any Registration Statement in which the Investor is participating, the Investor agrees to indemnify, hold harmless
and defend, to the same extent and in the same manner as is set forth in Section 6(a), the Company, each of its directors, each of
its officers who signs the Registration Statement and each Person, if any, who controls the Company within the meaning of the Securities
Act or the Exchange Act (each, an “Company Party”), against any Claim or Indemnified Damages to which any of
them may become subject, under the Securities Act, the Exchange Act or otherwise, insofar as such Claim or Indemnified Damages arise out
of or are based upon any Violation, in each case, to the extent, and only to the extent, that such Violation occurs in reliance upon and
in conformity with written information relating to the Investor furnished to the Company by the Investor expressly for use in connection
with such Registration Statement, the Prospectus included therein or any Prospectus Supplement thereto (it being hereby acknowledged and
agreed that the written information set forth on Exhibit C attached hereto is the only written information furnished
to the Company by or on behalf of the Investor expressly for use in any Registration Statement, Prospectus or Prospectus Supplement);
and, subject to Section 6(c) and the below provisos in this Section 6(b), the Investor shall reimburse a Company Party any legal
or other expenses reasonably incurred by such Company Party in connection with investigating or defending any such Claim; provided, however,
the indemnity agreement contained in this Section 6(b) and the agreement with respect to contribution contained in Section 7
shall not apply to amounts paid in settlement of any Claim if such settlement is effected without the prior written consent of the Investor,
which consent shall not be unreasonably withheld or delayed; and provided, further that the Investor shall
be liable under this Section 6(b) for only that amount of a Claim or Indemnified Damages as does not exceed the net proceeds to the
Investor as a result of the applicable sale of Registrable Securities pursuant to such Registration Statement, Prospectus or Prospectus
Supplement. Such indemnity shall remain in full force and effect regardless of any investigation made by or on behalf of such Company
Party and shall survive the transfer of any of the Registrable Securities by the Investor pursuant to Section 9.

 

    13

     

    

 

(c)
Promptly after receipt by an Investor Party or Company Party (as the case may be) under this Section 6 of notice of the commencement
of any action or proceeding (including, without limitation, any governmental action or proceeding) involving a Claim, such Investor Party
or Company Party (as the case may be) shall, if a Claim in respect thereof is to be made against any indemnifying party under this Section 6,
deliver to the indemnifying party a written notice of the commencement thereof, and the indemnifying party shall have the right to participate
in, and, to the extent the indemnifying party so desires, jointly with any other indemnifying party similarly noticed, to assume control
of the defense thereof with counsel mutually satisfactory to the indemnifying party and the Investor Party or the Company Party (as the
case may be); provided, however, an Investor Party or Company Party (as the case may be) shall have the right to retain
its own counsel with the fees and expenses of such counsel to be paid by the indemnifying party if: (i) the indemnifying party has
agreed in writing to pay such fees and expenses; (ii) the indemnifying party shall have failed promptly to assume the defense of
such Claim and to employ counsel reasonably satisfactory to such Investor Party or Company Party (as the case may be) in any such Claim;
or (iii) the named parties to any such Claim (including, without limitation, any impleaded parties) include both such Investor Party
or Company Party (as the case may be) and the indemnifying party, and such Investor Party or such Company Party (as the case may be) shall
have been advised by counsel that a conflict of interest is likely to exist if the same counsel were to represent such Investor Party
or such Company Party and the indemnifying party (in which case, if such Investor Party or such Company Party (as the case may be) notifies
the indemnifying party in writing that it elects to employ separate counsel at the expense of the indemnifying party, then the indemnifying
party shall not have the right to assume the defense thereof on behalf of the indemnified party and such counsel shall be at the expense
of the indemnifying party, provided further that in the case of clause (iii) above the indemnifying
party shall not be responsible for the reasonable fees and expenses of more than one (1) separate legal counsel for all Investor
Parties or Company Parties (as the case may be). The Company Party or Investor Party (as the case may be) shall reasonably cooperate with
the indemnifying party in connection with any negotiation or defense of any such action or Claim by the indemnifying party and shall furnish
to the indemnifying party all information reasonably available to the Company Party or Investor Party (as the case may be) which relates
to such action or Claim. The indemnifying party shall keep the Company Party or Investor Party (as the case may be) reasonably apprised
at all times as to the status of the defense or any settlement negotiations with respect thereto. No indemnifying party shall be liable
for any settlement of any action, claim or proceeding effected without its prior written consent; provided, however,
the indemnifying party shall not unreasonably withhold, delay or condition its consent. No indemnifying party shall, without the prior
written consent of the Company Party or Investor Party (as the case may be), consent to entry of any judgment or enter into any settlement
or other compromise which does not include as an unconditional term thereof the giving by the claimant or plaintiff to such Company Party
or Investor Party (as the case may be) of a release from all liability in respect to such Claim or litigation, and such settlement shall
not include any admission as to fault on the part of the Company Party. For the avoidance of doubt, the immediately preceding sentence
shall apply to Sections 6(a) and 6(b) hereof. Following indemnification as provided for hereunder, the indemnifying party shall be subrogated
to all rights of the Company Party or Investor Party (as the case may be) with respect to all third parties, firms or corporations relating
to the matter for which indemnification has been made. The failure to deliver written notice to the indemnifying party within a reasonable
time of the commencement of any such action shall not relieve such indemnifying party of any liability to the Investor Party or Company
Party (as the case may be) under this Section 6, except to the extent that the indemnifying party is materially and adversely prejudiced
in its ability to defend such action.

 

(d)
No Person involved in the sale of Registrable Securities who is guilty of fraudulent misrepresentation (within the meaning of Section 11(f)
of the Securities Act) in connection with such sale shall be entitled to indemnification from any Person involved in such sale of Registrable
Securities who is not guilty of fraudulent misrepresentation.

 

(e)
The indemnification required by this Section 6 shall be made by periodic payments of the amount thereof during the course of the
investigation or defense, as and when bills are received or Indemnified Damages are incurred; provided that any Person
receiving any payment pursuant to this Section 6 shall promptly reimburse the Person making such payment for the amount of such payment
to the extent a court of competent jurisdiction determines that such Person receiving such payment was not entitled to such payment.

 

    14

     

    

 

(f)
The indemnity and contribution agreements contained herein shall be in addition to (i) any cause of action or similar right of the
Company Party or Investor Party against the indemnifying party or others, and (ii) any liabilities the indemnifying party may be
subject to pursuant to the law.

 

	7.	Contribution.

 

To
the extent any indemnification by an indemnifying party is prohibited or limited by law, the indemnifying party agrees to make the maximum
contribution with respect to any amounts for which it would otherwise be liable under Section 6 to the fullest extent permitted by
law; provided, however: (i) no contribution shall be made under circumstances where the maker would not have
been liable for indemnification under the fault standards set forth in Section 6 of this Agreement, (ii) no Person involved
in the sale of Registrable Securities which Person is guilty of fraudulent misrepresentation (within the meaning of Section 11(f)
of the Securities Act) in connection with such sale shall be entitled to contribution from any Person involved in such sale of Registrable
Securities who was not guilty of fraudulent misrepresentation; and (iii) contribution by any seller of Registrable Securities shall
be limited in amount to the amount of net proceeds received by such seller from the applicable sale of such Registrable Securities pursuant
to such Registration Statement. Notwithstanding the provisions of this Section 7, the Investor shall not be required to contribute,
in the aggregate, any amount in excess of the amount by which the net proceeds actually received by the Investor from the applicable sale
of the Registrable Securities subject to the Claim exceeds the amount of any damages that the Investor has otherwise been required to
pay, or would otherwise be required to pay under Section 6(b), by reason of such untrue or alleged untrue statement or omission or
alleged omission.

 

	8.	Reports Under the Exchange Act.

 

With
a view to making available to the Investor the benefits of Rule 144, the Company agrees to:

 

(a)
use its commercially reasonable efforts to make and keep public information available, as those terms are understood and defined in Rule
144;

 

(b)
use its commercially reasonable efforts to file with the Commission in a timely manner all reports and other documents required of the
Company under the Securities Act and the Exchange Act so long as the Company remains subject to such requirements (it being understood
that nothing herein shall limit any of the Company’s obligations under the Purchase Agreement) and the filing of such reports and
other documents is required for the applicable provisions of Rule 144;

 

(c)
furnish to the Investor, promptly upon request, (i) a written statement by the Company, if true, that it has complied with the reporting,
submission and posting requirements of Rule 144 and the Exchange Act, (ii) a copy of the most recent annual or quarterly report of
the Company and such other reports and documents so filed by the Company with the Commission if such reports are not publicly available
via EDGAR, and (iii) such other information as may be reasonably requested to permit the Investor to sell such securities pursuant
to Rule 144 without registration; and

 

    15

     

    

 

(d)
take such additional action as is reasonably requested by the Investor to enable the Investor to sell the Registrable Securities pursuant
to Rule 144, including, without limitation, delivering all such legal opinions, consents, certificates, resolutions and instructions to
the Company’s Transfer Agent as may be reasonably requested from time to time by the Investor and otherwise fully cooperate with
Investor and Investor’s broker to effect such sale of securities pursuant to Rule 144.

 

	9.	Assignment of Registration Rights.

 

Neither
the Company nor the Investor shall assign this Agreement or any of their respective rights or obligations hereunder.

 

	10.	Amendment or Waiver.

 

No
provision of this Agreement may be amended or waived by the parties from and after the date that is one (1) Trading Day immediately
preceding the date of filing of the Initial Registration Statement with the Commission in a manner that is expressly inconsistent with
such Initial Registration Statement. Subject to the immediately preceding sentence, no provision of this Agreement may be (i) amended
other than by a written instrument signed by both parties hereto or (ii) waived other than in a written instrument signed by the
party against whom enforcement of such waiver is sought. Failure of any party to exercise any right or remedy under this Agreement or
otherwise, or delay by a party in exercising such right or remedy, shall not operate as a waiver thereof.

 

	11.	Miscellaneous.

 

(a)
Solely for purposes of this Agreement, a Person is deemed to be a holder of Registrable Securities whenever such Person owns or is deemed
to own of record such Registrable Securities. If the Company receives conflicting instructions, notices or elections from two or more
Persons with respect to the same Registrable Securities, the Company shall act upon the basis of instructions, notice or election received
from such record owner of such Registrable Securities.

 

(b)
Any notices, consents, waivers or other communications required or permitted to be given under the terms of this Agreement shall be given
in accordance with Section 10.4 of the Purchase Agreement.

 

(c)
Failure of any party to exercise any right or remedy under this Agreement or otherwise, or delay by a party in exercising such right or
remedy, shall not operate as a waiver thereof. The Company and the Investor acknowledge and agree that irreparable damage would occur
in the event that any of the provisions of this Agreement were not performed in accordance with their specific terms or were otherwise
breached. It is accordingly agreed that either party shall be entitled to an injunction or injunctions to prevent or cure breaches of
the provisions of this Agreement by the other party and to enforce specifically the terms and provisions hereof (without the necessity
of showing economic loss and without any bond or other security being required), this being in addition to any other remedy to which either
party may be entitled by law or equity.

 

    16

     

    

 

(d)
All questions concerning the construction, validity, enforcement and interpretation of this Agreement shall be governed by the internal
laws of the State of Delaware, without giving effect to any choice of law or conflict of law provision or rule (whether of the State of
Delaware or any other jurisdictions) that would cause the application of the laws of any jurisdictions other than the State of Delaware.
Each party hereby irrevocably submits to the exclusive jurisdiction of the federal courts sitting in the State of Delaware, for the adjudication
of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein, and hereby irrevocably
waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of
any such court, that such suit, action or proceeding is brought in an inconvenient forum or that the venue of such suit, action or proceeding
is improper. Each party hereby irrevocably waives personal service of process and consents to process being served in any such suit, action
or proceeding by mailing a copy thereof to such party at the address for such notices to it under this Agreement and agrees that such
service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit
in any way any right to serve process in any manner permitted by law. If any provision of this Agreement shall be invalid or unenforceable
in any jurisdiction, such invalidity or unenforceability shall not affect the validity or enforceability of the remainder of this Agreement
in that jurisdiction or the validity or enforceability of any provision of this Agreement in any other jurisdiction. EACH PARTY HEREBY
IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE TO, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR
IN CONNECTION HEREWITH OR ARISING OUT OF THIS AGREEMENT OR ANY TRANSACTION CONTEMPLATED HEREBY.

 

(e)
The Transaction Documents set forth the entire agreement and understanding of the parties solely with respect to the subject matter thereof
and supersedes all prior and contemporaneous agreements, negotiations and understandings between the parties, both oral and written, solely
with respect to such matters. There are no promises, undertakings, representations or warranties by either party relative to subject matter
hereof not expressly set forth in the Transaction Documents. Notwithstanding anything in this Agreement to the contrary and without implication
that the contrary would otherwise be true, nothing contained in this Agreement shall limit, modify or affect in any manner whatsoever
(i) the conditions precedent to a Purchase contained in Article VII of the Purchase Agreement or (ii) any of the Company’s
obligations under the Purchase Agreement.

 

(f)
This Agreement shall inure to the benefit of and be binding upon the parties hereto and their respective successors. This Agreement is
not for the benefit of, nor may any provision hereof be enforced by, any Person, other than the parties hereto, their respective successors
and the Persons referred to in Sections 6 and 7 hereof.

 

(g)
The headings in this Agreement are for convenience of reference only and shall not limit or otherwise affect the meaning hereof. Unless
the context clearly indicates otherwise, each pronoun herein shall be deemed to include the masculine, feminine, neuter, singular and
plural forms thereof. The terms “including,” “includes,” “include” and words of like import shall
be construed broadly as if followed by the words “without limitation.” The terms “herein,” “hereunder,”
“hereof” and words of like import refer to this entire Agreement instead of just the provision in which they are found.

 

(h)
This Agreement may be executed in two or more identical counterparts, all of which shall be considered one and the same agreement and
shall become effective when counterparts have been signed by each party and delivered to the other party; provided that a facsimile signature
or signature delivered by e-mail in a “.pdf” format data file, including any electronic signature complying with
the U.S. federal ESIGN Act of 2000, e.g., www.docusign.com, www.echosign.adobe.com, etc., shall be considered due execution and shall
be binding upon the signatory thereto with the same force and effect as if the signature were an original signature.

 

(i)
Each party shall do and perform, or cause to be done and performed, all such further acts and things, and shall execute and deliver all
such other agreements, certificates, instruments and documents as any other party may reasonably request in order to carry out the intent
and accomplish the purposes of this Agreement and the consummation of the transactions contemplated hereby.

 

(j)
The language used in this Agreement will be deemed to be the language chosen by the parties to express their mutual intent and no rules
of strict construction will be applied against any party.

 

[Signature Pages Follow]

 

 

    17

     

    

 

IN WITNESS WHEREOF,
Investor and the Company have caused their respective signature page to this Registration Rights Agreement to be duly executed as of the
date first written above.

 

	 	COMPANY:
	 	 
	 	Nukkleus Inc.
	 	 	 
	 	By:	/s/ Emil Assentato
	 	 	Name: Emil Assentato
	 	 	Title: Chief Executive Officer

 

	 	INVESTOR:
	 	 
	 	WHITE LION CAPITAL, LLC
	 	 	 
	 	By:	/s/ Nathan Yee
	 	 	Name: Nathan Yee
	 	 	Title: Managing Partner

  

     

     

    

 

EXHIBIT A

 

FORM OF NOTICE OF EFFECTIVENESS

OF REGISTRATION
STATEMENT

 

Re: Nukkleus Inc.

 

Ladies and Gentlemen:

 

We
are counsel to Nukkleus Inc., a Delaware corporation (the “Company”), and have represented the Company in connection
with that certain Common Stock Purchase Agreement, dated as of [____] (the
“Purchase Agreement”), entered into by and among the Company and the Investor named therein (the “Holder”)
pursuant to which the Company will issue to the Holder from time to time shares of the Company’s Common Stock (the ”Common
Stock”). Pursuant to the Purchase Agreement, the Company also has entered into a Registration Rights Agreement, dated as
of [____], with the Holder (the “Registration
Rights Agreement”), pursuant to which the Company agreed, among other things, to register the offer and sale by the Holder
of the Registrable Securities (as defined in the Registration Rights Agreement) under the Securities Act of 1933, as amended (the “Securities
Act”). In connection with the Company’s obligations under the Registration Rights Agreement, on May [____],
2022, the Company filed a Registration Statement on Form S-1 (File No. 333-[●]) (the “Registration Statement”)
with the Securities and Exchange Commission (the “Commission”) relating to the Registrable Securities which
names the Holder as an underwriter and a selling stockholder thereunder.

 

In
connection with the foregoing, based solely on our review of the Commission’s EDGAR website, we advise you that the Registration
Statement became effective under the Securities Act on [●], 2022. In addition, based solely on our review of the information made
available by the Commission at http://www.sec.gov/litigation/stoporders.shtml, we confirm that the Commission has not issued any stop
order suspending the effectiveness of the Registration Statement. To our knowledge, based solely on our participation in the conferences
mentioned above regarding the Registration Statement and our review of the information made available by the Commission at http://www.sec.gov/litigation/stoporders.shtml,
no proceedings for that purpose are pending or have been instituted or threatened by the Commission.

 

We
assume no obligation to update or supplement this letter to reflect any facts or circumstances which may hereafter come to our attention
with respect to the matters herein and statements expressed above, including any changes in applicable law that may hereafter occur.

 

This
letter is being delivered solely for the benefit of the person to whom it is addressed; accordingly, it may not be quoted, filed with
any governmental authority or other regulatory agency or otherwise circulated or utilized for any purposes without our prior written consent.

 

	 	Very truly yours,
	 	 
	 	[ISSUER’S COUNSEL]
	 	 	 
	 	By:	     

 

cc: White Lion Capital, LLC

 

     

     

    

 

EXHIBIT B

 

SELLING STOCKHOLDER

 

This
prospectus relates to the possible resale from time to time by White Lion Capital of any or all of the shares of common stock that may
be issued by us to White Lion Capital under the Purchase Agreement. For additional information regarding the issuance of common stock
covered by this prospectus, see the section titled “White Lion Capital Committed Equity Financing” above. We are registering
the shares of common stock pursuant to the provisions of the Registration Rights Agreement we entered into with White Lion Capital on
{} in order to permit the selling stockholder to offer the shares for resale from time to time. Except for the transactions contemplated
by the Purchase Agreement and the Registration Rights Agreement or as otherwise disclosed in this prospectus, White Lion Capital has not
had any material relationship with us within the past three years. As used in this prospectus, the term “selling stockholder”
means White Lion Capital, LLC.

 

The
table below presents information regarding the selling stockholder and the shares of common stock that it may offer from time to time
under this prospectus. This table is prepared based on information supplied to us by the selling stockholder, and reflects holdings as
of [●], 2022. The number of shares in the column “Maximum Number of Shares of Common Stock to be Offered Pursuant to this Prospectus”
represents all of the shares of common stock that the selling stockholder may offer under this prospectus. The selling stockholder may
sell some, all or none of its shares in this offering. We do not know how long the selling stockholder will hold the shares before selling
them, and we currently have no agreements, arrangements or understandings with the selling stockholder regarding the sale of any of the
shares.

 

Beneficial
ownership is determined in accordance with Rule 13d-3(d) promulgated by the SEC under the Exchange Act, and includes shares
of common stock with respect to which the selling stockholder has voting and investment power. The percentage of shares of common stock
beneficially owned by the selling stockholder prior to the offering shown in the table below is based on an aggregate of [●] shares
of our common stock outstanding on [●], 2022. Because the purchase price of the shares of common stock issuable under the Purchase
Agreement is determined on the Purchase Settlement Date with respect to each Purchase, the number of shares that may actually be sold
by the Company under the Purchase Agreement may be fewer than the number of shares being offered by this prospectus. The fourth column
assumes the sale of all of the shares offered by the selling stockholder pursuant to this prospectus.

 

	

Name of Selling Stockholder	 	Number of Shares of

Common Stock

Owned Prior to

Offering	 	 	Maximum Number of

Shares of Common Stock

to be Offered Pursuant to

this Prospectus	 	 	Number of Shares of

Common Stock

Owned After Offering	 
	 	 	Number(1)	 	Percent(2)	 	 	 	 	 	Number(3)	 	 	Percent(2)	 
	White Lion Capital, LLC(4)	 	[ ●]	 	*	 	 	 	[●]	 	 	0	 	 	—	 

 

	*	Represents beneficial ownership of less than 1% of the outstanding shares of our common stock.

 

	(1)	In accordance with Rule 13d-3(d) under the Exchange Act, we have excluded from the number of shares beneficially owned prior to the offering all of the shares that White Lion Capital may be required to purchase under the Purchase Agreement, because the issuance of such shares is solely at our discretion and is subject to conditions contained in the Purchase Agreement, the satisfaction of which are entirely outside of White Lion Capital’s control, including the registration statement that includes this prospectus becoming and remaining effective. Furthermore, the Purchase of common stock are subject to certain agreed upon maximum amount limitations set forth in the Purchase Agreement. Also, the Purchase Agreement prohibits us from issuing and selling any shares of our common stock to White Lion Capital to the extent such shares, when aggregated with all other shares of our common stock then beneficially owned by White Lion Capital, would cause White Lion Capital’s beneficial ownership of our common stock to exceed the 4.99% Beneficial Ownership Cap. The Purchase Agreement also prohibits us from issuing or selling shares of our common stock under the Purchase Agreement in excess of the 19.99% Exchange Cap, unless we obtain stockholder approval to do so, or unless sales of common stock are made at a price equal to or greater than $[●] per share, such that the Exchange Cap limitation would not apply under applicable Nasdaq rules. Neither the Beneficial Ownership Limitation nor the Exchange Cap (to the extent applicable under Nasdaq rules) may be amended or waived under the Purchase Agreement.

 

	(2)	Applicable percentage ownership is based on [●] shares of our common stock outstanding as of [●], 2022.

 

	(3)	Assumes the sale of all shares being offered pursuant to this prospectus.

 

	(4)	The business address of White Lion Capital, LLC (“WLC”) is 17631 Ventura Blvd., Suite 1008, Encino, CA 91316. WLC’s principal business is that of a private investor. Dmitriy Slobodskiy Jr., Yash Thukral, SamYaffa, and Nathan Yee are the managing principals of WLC. Therefore, each of Slobodskiy Jr., Thukral, Yaffa, and Yee may be deemed to have sole voting control and investment discretion over securities beneficially owned directly by WLC and, indirectly, by WLC. We have been advised that WLC is not a member of the Financial Industry Regulatory Authority, or FINRA, or an independent broker-dealer. The foregoing should not be construed in and of itself as an admission by Slobodskiy Jr., Thukral, Yaffa, and Yee as to beneficial ownership of the securities beneficially owned directly by WLC and, indirectly, by WLC.

 

     

     

    

 

PLAN OF DISTRIBUTION

 

The
shares of common stock offered by this prospectus are being offered by the selling stockholder, White Lion Capital, LLC. The shares may
be sold or distributed from time to time by the selling stockholder directly to one or more purchasers or through brokers, dealers, or
underwriters who may act solely as agents at market prices prevailing at the time of sale, at prices related to the prevailing market
prices, at negotiated prices, or at fixed prices, which may be changed. The sale of the shares of our common stock offered by this prospectus
could be effected in one or more of the following methods:

 

	 	●	ordinary brokers’ transactions;

 

	 	●	transactions involving cross or block trades;

 

	 	●	through brokers, dealers, or underwriters who may act solely as agents;

 

	 	●	“at the market” into an existing market for our common stock;

 

	 	●	in other ways not involving market makers or established business markets, including direct sales to purchasers or sales effected through agents;

 

	 	●	in privately negotiated transactions; or

 

	 	●	any combination of the foregoing.

 

In
order to comply with the securities laws of certain states, if applicable, the shares may be sold only through registered or licensed
brokers or dealers. In addition, in certain states, the shares may not be sold unless they have been registered or qualified for sale
in the state or an exemption from the state’s registration or qualification requirement is available and complied with.

 

White
Lion Capital is an “underwriter” within the meaning of Section 2(a)(11) of the Securities Act.

 

White
Lion Capital has informed us that it intends to use one or more registered broker-dealers (one of which is an affiliate of White Lion
Capital) to effectuate all sales, if any, of our common stock that it may acquire from us pursuant to the Purchase Agreement. Such sales
will be made at prices and at terms then prevailing or at prices related to the then current market price. Each such registered broker-dealer
will be an underwriter within the meaning of Section 2(a)(11) of the Securities Act. White Lion Capital has informed us that each
such broker-dealer may receive commissions from White Lion Capital and, if so, such commissions will not exceed customary brokerage commissions.

 

Brokers,
dealers, underwriters or agents participating in the distribution of the shares of our common stock offered by this prospectus may receive
compensation in the form of commissions, discounts, or concessions from the purchasers, for whom the broker-dealers may act as agent,
of the shares sold by the selling stockholder through this prospectus. The compensation paid to any such particular broker-dealer by any
such purchasers of shares of our common stock sold by the selling stockholder may be less than or in excess of customary commissions.
Neither we nor the selling stockholder can presently estimate the amount of compensation that any agent will receive from any purchasers
of shares of our common stock sold by the selling stockholder.

 

     

     

    

 

We
know of no existing arrangements between the selling stockholder or any other stockholder, broker, dealer, underwriter or agent relating
to the sale or distribution of the shares of our common stock offered by this prospectus.

 

We
may from time to time file with the SEC one or more supplements to this prospectus or amendments to the registration statement of which
this prospectus forms a part to amend, supplement or update information contained in this prospectus, including, if and when required
under the Securities Act, to disclose certain information relating to a particular sale of shares offered by this prospectus by the selling
stockholder, including the names of any brokers, dealers, underwriters or agents participating in the distribution of such shares by the
selling stockholder, any compensation paid by the selling stockholder to any such brokers, dealers, underwriters or agents, and any other
required information.

 

As
consideration for its irrevocable commitment to purchase our Common Stock under the Purchase Agreement, on [●], 2022, we issued to
White Lion Capital [●] Shares as Commitment Shares.

 

We
also have agreed to indemnify White Lion Capital and certain other persons against certain liabilities in connection with the offering
of shares of our common stock offered hereby, including liabilities arising under the Securities Act or, if such indemnity is unavailable,
to contribute amounts required to be paid in respect of such liabilities. White Lion Capital has agreed to indemnify us against liabilities
under the Securities Act that may arise from certain written information furnished to us by White Lion Capital specifically for use in
this prospectus or, if such indemnity is unavailable, to contribute amounts required to be paid in respect of such liabilities. Insofar
as indemnification for liabilities arising under the Securities Act may be permitted to our directors, officers, and controlling persons,
we have been advised that in the opinion of the SEC this indemnification is against public policy as expressed in the Securities Act and
is therefore, unenforceable.

 

We
estimate that the total expenses for the offering will be approximately $.

 

White
Lion Capital has represented to us that at no time prior to the date of the Purchase Agreement has White Lion Capital, any of its affiliates
or any entity managed or controlled by White Lion Capital engaged in or effected, directly or indirectly, for its own principal account,
any short sale (as such term is defined in Rule 200 of Regulation SHO of the Exchange Act) of our common stock that establishes a net
short position with respect to our common stock. White Lion Capital has agreed that during the term of the Purchase Agreement, none of
White Lion Capital, any of its affiliates nor any entity managed or controlled by White Lion Capital will enter into or effect, directly
or indirectly, any of the foregoing transactions for its own principal account or for the principal account of any other such entity.

 

We
have advised the selling stockholder that it is required to comply with Regulation M promulgated under the Exchange Act. With certain
exceptions, Regulation M precludes the selling stockholder, any affiliated purchasers, and any broker-dealer or other person who participates
in the distribution from bidding for or purchasing, or attempting to induce any person to bid for or purchase any security which is the
subject of the distribution until the entire distribution is complete. Regulation M also prohibits any bids or purchases made in order
to stabilize the price of a security in connection with the distribution of that security. All of the foregoing may affect the marketability
of the securities offered by this prospectus.

 

This
offering will terminate on the date that all shares of our common stock offered by this prospectus have been sold by the selling stockholder.

 

Our
common stock is currently listed on The Nasdaq Capital Market under the symbol “NUKK”.

 

     

     

    

 

EXHIBIT C

 

The business address
of White Lion Capital, LLC (“WLC”) is 17631 Ventura Blvd #1008, Encino, CA 91316. WLC’s principal business is that of
a private investor. Dmitriy Slobodskiy Jr., Yash Thukral, SamYaffa, and Nathan Yee are the managing principals of WLC.. Therefore,
each of Slobodskiy Jr., Thukral, Yaffa, and Yee may be deemed to have sole voting control and investment discretion over securities beneficially
owned directly by WLC and, indirectly, by WLC. We have been advised that WLC is not a member of the Financial Industry Regulatory Authority,
or FINRA, or an independent broker-dealer. The foregoing should not be construed in and of itself as an admission by Slobodskiy Jr., Thukral,
Yaffa, and Yee as to beneficial ownership of the securities beneficially owned directly by WLC and, indirectly, by WLC.

 

White Lion Capital has
represented to us that at no time prior to the date of the Purchase Agreement has White Lion Capital or, any of its agents, representatives
or affiliates or any entity managed or controlled by White Lion Capital engaged in or effected, in any manner whatsoever, directly or
indirectly, for its own principal account, any short sale (as such term is defined in Rule 200 of Regulation SHO of the Exchange Act)
of our common stock, which that establishes a net short position with respect to our common stock. White Lion Capital has agreed that
during the term of the Purchase Agreement, neither of White Lion Capital, nor any of its agents, representatives or affiliates nor any
entity managed or controlled by White Lion Capital will enter into or effect, directly or indirectly, any of the foregoing transactions
for its own principal account or for the principal account of any other such entity.Exhibit 10.1

 

TRANSITION SUPPORT AGREEMENT AND GENERAL RELEASE

 

THIS TRANSITION SUPPORT
AGREEMENT AND GENERAL RELEASE (the “Agreement and General Release”) is made and entered into on May 6, 2022 by
and among Susan Sholtis (“Executive”) and PetIQ, LLC, an Idaho limited liability company (“Employer”).
Executive’s last day of employment will be May 27, 2022 (the “Retirement Date”).

 

WHEREAS, Executive
has been employed by Employer pursuant to the Employment and Non-Competition Agreement by and between the Employer and the Executive dated
September 17, 2018, as amended by the Amendment to Employment and Non-Competition Agreement dated as of October 5, 2018 (the “Employment
Agreement”);

 

WHEREAS, the parties
now wish to provide for the transition of Executive’s employment and resolve all outstanding claims and disputes between them relating
to such employment in anticipation of Executive’s retirement on the Retirement Date; and

 

WHEREAS, the press release for Executive’s retirement
is attached as Exhibit A hereto.

 

NOW, THEREFORE,
in consideration of the mutual promises, covenants and agreements set forth in this Agreement and General Release, the sufficiency of
which the parties acknowledge, it is agreed as follows:

 

		1.	Executive shall execute and deliver this Agreement and General
Release no later than the twenty-first (21st) day after Executive’s receipt of this Agreement and General Release;. Executive acknowledges
and agrees that she will continue to serve the Employer in a professional and courteous manner and to the best of her ability, consistent
with the duties and responsibilities of her position as President (“President”) of Employer, through the Retirement
Date . From the effective date of this Agreement and General Release through September 30, 2022 (the “Transition Period”),
and without limiting Executive’s post-termination assistance obligations pursuant to Section 2(d) of the Employment Agreement,
Executive shall provide transition services to the best of her ability and in a diligent, businesslike and efficient manner, including
working with the Employer’s executive management team and direct reports to transition the business, assisting with knowledge transfer,
building-out the relationships with Executive’s direct reports and applicable third parties, and performing other transition services
as may be assigned to Executive from time to time by the Chief Executive Officer of Employer or the board of directors of PetIQ, Inc.
(the “Board”). Notwithstanding the foregoing, Employer may terminate Executive prior to the Retirement Date for Cause
(as defined in the Employment Agreement) or breach of this Agreement and General Release, which shall include Executive’s failure
to use her best efforts to perform the services at Employer’s direction through the Retirement Date, and Executive shall not be
entitled to any additional payment hereunder. Provided that Executive’s employment is not terminated for Cause, due to death or
Disability (as defined in the Employment Agreement), due to Executive’s breach of this Agreement and General Release or due to
Executive’s voluntary resignation, Executive shall continue to receive her current base salary and be allowed to remain as an active
participant in the retirement, health and welfare benefit plans sponsored by the Employer during through the Retirement Date.

 

     

     

    

 

		2.	In consideration for Executive’s promises, covenants and agreements in this Agreement and General
Release, Employer agrees to (i) pay as severance Executive’s base salary for a period of twelve (12) months, less applicable withholdings,
in accordance with the Employer’s payroll practices commencing at the first payroll period following the expiration of the Revocation
Period referenced in Section 13 of this Agreement and General Release; and (ii) to the extent that Executive is eligible for and elects
continuation coverage under the Consolidated Omnibus Budget Reconciliation Act of 1985 (“COBRA”), to provide Executive
one hundred percent (100%) subsidized continuation coverage under COBRA in effect as of the Retirement Date on an after-tax basis for
herself and her eligible dependents through the earlier of (A) the end of the eighteen (18) month period following the Retirement Date
(the “COBRA Period”) and (B) the date on which Executive becomes eligible for a group health plan with another employer.
In addition, to the extent Executive is not eligible for a group health plan with another employer, Employer shall reimburse Executive
for hundred percent (100%) of the reasonable premiums for health care coverage for herself and her eligible dependents, on an after-tax
basis, for six (6) months following the COBRA Period. The foregoing amounts are intended to constitute all severance benefits or other
payments to which Executive may be eligible to receive under the Employment Agreement or otherwise and the Executive shall not be entitled
to any other payments or benefits thereunder.

 

		3.	The parties agree that the payments and benefits described
in Section 2 and the treatment of incentive equity set forth in Section 4 of this Agreement and General Release are in full, final and
complete settlement of all claims Executive may have against Employer or its past and present parents, subsidiaries or affiliates, including,
but not limited to, PetIQ, Inc. and PetIQ Holdings, LLC, a Delaware limited liability company, and the respective officers, directors,
owners, members, shareholders, employees, agents, advisors, consultants, insurers, attorneys, successors and/or assigns of each of the
foregoing (collectively, the “Releasees”). For the avoidance of doubt, this Agreement and General Release provides
for the sole and exclusive benefits for which Executive is eligible as a result of Executive’s termination of employment, and Executive
shall not be eligible for any payments or benefits under any other agreement or arrangement with any Releasee providing for payments,
or benefits upon a separation from service or any retention, sale, transaction, phantom equity, or other incentive payments, including
any severance or termination provisions set forth in the Employment Agreement related to a termination without Cause (as such term is
defined in the Employment Agreement).

 

		4.	(a) With respect to all stock options and restricted stock units granted to Executive as of the date hereof
pursuant to certain Nonqualified Stock Option Agreements and certain Restricted Stock Unit Agreements (collectively, the “Stock
Awards”), each by and between Employer and Executive and issued under the PetIQ, Inc. 2017 Omnibus Incentive Plan, as in effect
and as amended from time to time (the “Stock Plan”), all unvested amounts shall continue to vest pursuant to the terms
of the Stock Awards and the Stock Plan as though Executive were employed by Employer up to and including May 27, 2023.

 

(b) Executive and Employer
acknowledge and agree that each Stock Award that constitutes a nonqualified stock option is hereby amended such that the exercise
period for such Stock Awards shall be extended through May 27, 2024 (the “Exercise Deadline”). Executive
acknowledges and agrees that any such Stock Awards that remain unexercised as of the Exercise Deadline shall be forfeited in their
entirety without payment or other consideration.

 

    2 

     

    

 

		5.	Executive acknowledges and agrees that she shall continue
to abide by all applicable policies of Employer during and after the Transition Period, as applicable, including, but not limited to,
such policies set forth in the Employer’s Employee Handbook, Code of Business Conduct and Ethics, Code of Ethics for Senior Financial
Officers, insider trading policy and clawback policy.

 

		6.	Nothing in this Agreement and General Release shall be construed as an admission of liability by Employer
or any other Releasee, and Employer specifically disclaims liability to or wrongful treatment of Executive on the part of itself and all
other Releasees.

 

		7.	To the extent permitted by applicable law, Executive agrees
that Executive will not encourage or assist any person to litigate claims or file administrative charges against the Employer or any
other Releasee, unless required to provide testimony or documents pursuant to a lawful subpoena or other compulsory legal process, in
which case Executive agrees to notify the Employer immediately of Executive receipt of such subpoena so that the Employer has the opportunity
to contest the same. If any court has or assumes jurisdiction of any action against the Employer or any of its affiliates on behalf of
Executive, Executive will request that court to withdraw from or dismiss the matter with prejudice.

 

		8.	Executive represents and warrants that Executive has not
filed any complaints or charges against Employer or any of its affiliates with the Equal Employment Opportunity Commission (“EEOC”),
or with any other federal, state or local agency or court, and covenants that Executive will not seek to recover on any claim released
in this Agreement and General Release.

 

		9.	In consideration for the payments and benefits set forth
in Section 2 of this Agreement and General Release and the benefits set forth in Section 4 of this Agreement and General Release, and
the other promises, agreements and undertakings contained herein, Executive covenants not to sue, and fully and forever releases and
discharges Employer and all other Releasees from any and all legally waivable claims, liabilities, damages, demands, and causes of action
or liabilities of any nature or kind, whether now known or unknown, from the beginning of time up to and including the date on which
Executive executes this Agreement and General Release, including but not limited to any and all such claims arising out of, relating
to, or in any way connected with Executive’s employment with Employer or any of its affiliates or subsidiaries, or the termination
of such employment; provided, however, that nothing in this Agreement and General Release shall either waive any rights or claims of
Executive (i) that arise after Executive signs this Agreement and General Release; (ii) to enforce the terms of this Agreement and General
Release; (iii) for the provision of vested benefits conferred to Executive or Executive beneficiaries under the terms of Employer’s
medical, dental, life insurance or defined contribution retirement benefit plans; or (iv) any right of Executive to indemnification under
the Employer’s Amended and Restated Bylaws, and to coverage under the Employer’s D&O insurance policies to the extent covered prior
to the Retirement Date. This release includes but is not limited to claims arising under federal, state or local laws, including but not
limited to Title VII of the Civil Rights Act of 1964, as amended, the Age Discrimination in Employment Act of 1967, as amended (the “ADEA”),
the Older Workers Benefit Protection Act, the Equal Pay Act of 1963, the Americans with Disabilities Act of 1990, as amended, the Worker
Adjustment and Retraining Notification Act of 1988, as amended, waivable claims under the Employee Retirement Income Security Act of 1974,
as amended (“ERISA”) (including but not limited to fiduciary claims), waivable claims under the Fair Labor Standards
Act, the Family Medical Leave Act, claims for attorneys’ fees or costs, any and all statutory or common law provisions relating
to or affecting Executive’s employment with Employer or its affiliates or concerning employment discrimination, termination, retaliation
and equal opportunity, and any and all claims in contract, tort, or premised on any other legal theory. Executive acknowledges that Executive
is releasing claims based on age, race, color, sex, sexual orientation or preference, marital status, religion, national origin, citizenship,
veteran status, disability and other legally protected categories. This provision is intended to constitute a general release of all of
Executive’s presently existing covered claims against the Releasees, to the maximum extent permitted by law. Executive hereby represents
and warrants to Employer that Executive has not assigned, transferred, sold, encumbered, pledged, hypothecated, mortgaged, distributed,
or otherwise disposed of or conveyed to any third party any right or claim against Employer which has been released in this Agreement
and General Release.

 

    3 

     

    

 

		10.	Nothing in this Agreement and General Release shall be construed
to: (a) waive any claim for worker’s compensation or unemployment benefits; (b) waive or affect any claim that cannot be released
by an agreement voluntarily entered into between private parties; (c) limit Executive’s ability to file a charge or complaint with
the EEOC, the National Labor Relations Board, the Occupational Safety and Health Administration, the Securities and Exchange Commission
or any other federal, state or local governmental agency or commission (“Government Agencies”); (d) limit Executive’s
ability to communicate with any Government Agencies or otherwise participate in any investigation or proceeding that may be conducted
by any Government Agency, including providing documents or other information, without notice to the Employer; (e) release claims challenging
the validity of this Agreement and General Release under the ADEA; (f) waive any rights of Executive with respect to vested equity held
by her in the Employer; or (g) release the Employer from its obligations under this Agreement and General Release. Executive expressly
waives and agrees to waive any right to recover monetary damages for personal injuries in any charge, complaint or lawsuit filed by Executive
or anyone else on behalf of Executive for any released claims. This Agreement and General Release does not limit Executive’s right
to receive an award for information provided to any Government Agencies.

 

		11.	Executive acknowledges that all Confidential Information,
defined herein, regarding Employer’s or any of its affiliates’ business compiled, created or obtained by, or furnished to,
Executive during the course of or in connection with Executive’s employment with Employer or any of its subsidiaries (the “Group”)
is the exclusive property of Employer or such subsidiary. For purposes of this
Agreement and General Release, “Confidential Information” shall include, but is not limited to, all information not
generally known to the public relating to the Group’s business processes, practices, methods, strategies, techniques, financial information, marketing
information, pricing information, design information, personnel information, employee lists, market studies, agreements, proposals, database
information, customer and prospective customer information and customer and prospective customer lists. Upon or before execution of this
Agreement and General Release, Executive will return to Employer all originals and copies of any material containing Confidential Information,
and Executive further agrees that Executive will not, directly or indirectly, use or disclose such information, except as required by
law or in any judicial or administrative proceeding with subpoena power. Executive will also return to Employer upon or before the Retirement
Date any other items in Executive possession, custody or control that are the property of the Group, including, but not limited to, Executive
files, laptop, credit cards, power cords, credit card issued by the Group, identification card, data storage devices, passwords and office
fob/keys.

 

    4 

     

    

 

		12.	In consideration for the payments and benefits outlined in
this Agreement and General Release, Executive acknowledges and agrees that she continues to be bound by the post-termination cooperation
and non-assistance covenants set forth in Sections 2(d) and 2(e) of the Employment Agreement, the resignation upon termination provisions
set forth in Section 3(d) of the Employment Agreement, the restrictive covenant related provisions set forth in Sections 4 (Non-Compete;
Non-Solicitation), 5 (Nondisclosure and Nonuse of Confidential Information), 6 (Property; Inventions and Patents), 7 (Acknowledgement
and Enforcement), 9 (Non-Disparagement), 10 (Termination of Severance Payments), and 11(a) (Severability) of the Employment Agreement,
and the arbitration and waiver of jury trial provisions set forth in Section 11(k) of the Employment Agreement (collectively, the “Surviving
Provisions”), and Section 7 of the Stock Awards. Executive acknowledges and agrees that the foregoing provisions are incorporated
herein by reference.

 

		13.	Executive acknowledges that (i) Executive has been given
at least twenty-one (21) calendar days to consider this Agreement and General Release and that modifications hereof which are mutually
agreed upon by the parties hereto, whether material or immaterial, do not restart the twenty-one (21) day period; (ii) Executive has
seven (7) calendar days from the date Executive executes this Agreement and General Release (the “Revocation Period”)
in which to revoke it; and (iii) this Agreement and General Release will not be effective or enforceable nor the amounts set in Section
2 and the benefits set forth in Section 4 of this Agreement and General Release paid unless the seven-day Revocation Period ends without
revocation by Executive. Revocation can be made by delivery and receipt of a written notice of revocation to R. Michael Herrman, Michael.Herrman@petiq.com,
by midnight on or before the seventh calendar day after Executive signs the Agreement and General Release.

 

		14.	Executive acknowledges that Executive has been advised to
consult with an attorney of Executive’s choice with regard to this Agreement and General Release. Executive hereby acknowledges
that Executive understands the significance of this Agreement and General Release, and represents that the terms of this Agreement and
General Release are fully understood and voluntarily accepted by Executive.

 

    5 

     

    

 

		15.	In the event of any lawsuit against Employer or any of its
affiliates that relates to alleged acts or omissions by Executive during her employment with Employer, Executive agrees to cooperate with Employer or its affiliate
by voluntarily providing truthful and full information as reasonably necessary for Employer or its affiliate to defend against such lawsuit,
provided that Employer shall reimburse Executive’s reasonable expenses incurred in providing such assistance subject to Executive’s
delivery of written notice to Employer prior to the time such expenses are incurred.

 

		16.	This Agreement and General Release shall be binding on Employer
and Executive and upon their respective heirs, representatives, successors and assigns, and shall run to the benefit of the Releasees
and each of them and to their respective heirs, representatives, successors and assigns.

 

		17.	Executive acknowledges and agrees that Executive has carefully
read this Agreement and General Release and understands that it is a release of all claims, known and unknown, past or present, including
all claims under the ADEA. Executive warrants that Executive is executing this Agreement and General Release without any representation
of any kind or character by Employer or its affiliates not expressly set forth herein.

 

		18.	(a) It is intended that any amounts payable under this Agreement
and General Release shall be exempt from and avoid the imputation of any tax, penalty or interest under Section 409A of the Internal
Revenue Code of 1986, as amended and the regulations, rules and other guidance promulgated thereunder (collectively, “Section
409A”) to the fullest extent permissible under applicable law; provided that if any such amount is or becomes subject to the
requirements of Section 409A, it is intended that those amounts shall comply with such requirements. This Agreement and General Release
shall be construed and interpreted consistent with that intent. In furtherance of that intent, if payment or provision of any amount
or benefit hereunder that is subject to Section 409A at the time specified herein would subject such amount or benefit to any additional
tax under Section 409A, the payment or provision of such amount or benefit shall be postponed to the earliest commencement date on which
the payment or provision of such amount or benefit could be made without incurring such additional tax. In no event, however, shall the
Employer be liable for any tax, interest or penalty imposed on Executive under Section 409A or any damages for failing to comply with
Section 409A.

 

(b) Executive acknowledges and
agrees that as of the Retirement Date she is a “specified employee” within the meaning of Treasury Regulation Section
1.409A-1(i) and, therefore, Executive shall not be entitled to any payment or benefit pursuant to this Agreement and General Release
that constitutes nonqualified deferred compensation for purposes of Section 409A and that is payable upon a separation from service
(within the meaning of Section 409A) until the earlier of (A) the date which is six (6) months after her separation from service for
any reason other than death, or (B) the date of Executive’s death; provided that this paragraph shall only apply if, and to
the extent, required to avoid the imputation of any tax, penalty or interest pursuant to Section 409A. Any amounts otherwise payable
to Executive upon or in the six (6) month period following Executive’s separation from service that are not so paid by reason
of this Section 5 shall be paid (without interest) as soon as practicable (and in any event within thirty (30) days) after the date
that is six (6) months after Executive’s separation from service (provided that in the event of Executive’s death after
such separation from service but prior to payment, then such payment shall be made as soon as practicable, and in all events within
thirty (30) days, after the date of Executive’s death).

 

(c) For purposes of Section 409A, Executive’s
right to receive any installment payments hereunder shall be treated as a right to receive a series of separate and distinct payments.
Whenever a payment under this Agreement and General Release specifies a payment period with reference to a number of days (e.g., payment
shall be made within thirty (30) days following a certain date), the actual date of payment within the specified period shall be within
the sole discretion of the Employer.

 

    6 

     

    

 

		19.	This Agreement and General Release, including the Surviving
Provisions, sets forth the entire agreement between Executive and Employer, and fully supersedes any and all prior agreements or understandings
between them regarding its subject matter. This Agreement and General Release may only be modified by written agreement signed by both
parties.

 

		20.	Executive acknowledges and agrees that if Executive has breached
any term of this Agreement and General Release, including, but not limited to, the Restrictive Covenants, then Executive will be obligated
to pay and return to Employer any payments and benefits paid under Section 2 and Section 4 on or after the date of such breach within
the thirty (30) days following the breach.

 

		21.	The Employer and Executive agree that in the event any provision
of this Agreement and General Release is deemed to be invalid or unenforceable by any court or administrative agency of competent jurisdiction,
or in the event that any provision cannot be modified so as to be valid and enforceable, then that provision shall be deemed severed
from the Agreement and General Release and the remainder of the Agreement and General Release shall remain in full force and effect.

 

		22.	This Agreement and General Release will be governed by and
construed in accordance with the laws of the State of Delaware without giving effect to any choice or conflict of law provision or rule
(whether of the State of Delaware or any other jurisdiction) that would cause the application of the laws of any jurisdiction other than
the State of Delaware.

 

		23.	To the extent permissible under applicable law, each of the parties hereto hereby irrevocably waives all
right to trial by jury in any action, proceeding or counterclaim arising out of or relating to this Agreement and General Release.

 

		24.	The language of all parts of this Agreement and General Release in all cases shall be construed as a whole,
according to its fair meaning, and not strictly for or against any of the parties.

 

*    
*    *    *

 

[Signature Page Follows]

 

    7 

     

    

  

PLEASE READ CAREFULLY. THIS

AGREEMENT AND GENERAL RELEASE INCLUDES A

 RELEASE OF ALL
KNOWN AND UNKNOWN CLAIMS.

 

	 	“EMPLOYER”
	 	 
	 	PETIQ, LLC
	 	 
	 	By:	/s/ McCord Christensen
	 	Name:	McCord Christensen
	 	Title:	CEO
	 	 
	 	PETIQ, LLC
	 	
	 	By:	/s/ R. Michael Herrman
	 	Name:	R. Michael Herrman
	 	Title:	EVP, General Counsel & Corp. Counsel
	 	 
	 	“EMPLOYEE”
	 	 
	 	/s/ Susan Sholtis
	 	Susan Sholtis
	 	 
	 	Date: May 6, 2022

 

     

     

    

  

EXHIBIT A: PRESS RELEASE

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00345-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00345-of-00352.parquet"}]]